V
Dexcom just got FDA clearance for an OTC glucose sensor.
Usually, the health tech I see at CES is vaporware, but good news! Dexcom’s Stelo continuous glucose biosensor just got FDA clearance, making it the first ever to not require a prescription. Stelo is meant to help folks with Type 2 diabetes who don’t use insulin better manage their condition.
It’ll be available starting this summer. We still don’t know pricing, but when I spoke with Dexcom in January they said it was meant to be an affordable.
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...
Most Popular
Most Popular
- Meta’s historic loss in court could cost a lot more than $375 million
- Apple raises the Mac Mini’s starting price
- How the internet’s favorite squirrel dad made the hottest camera app of 2026
- Spirit Airlines shuts down after Trump’s war on Iran doubled jet fuel prices
- Anker’s discounted 2-in-1 USB-C cable is a great way to spend $15
